| |
Top aids news news stories... |
|
| |
|
|
| |
Among HIV Patients In ICU, Mortality Rates Have Decreased, Chronic Disease Rates Have Increased |
|
| |
The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) patients nationwide, primarily due to a decrease in opportunistic infections, according to a new study by researchers at Stanford University... |
|
| |
|
|
| |
Research Links Abacavir Hypersensitivity Reactions In HIV To Attacks By Body's Own Immune System |
|
| |
Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according to a study published online by the journal AIDS, official journal of the International AIDS Society... |
|
| |
|
|
| |
News From The Journals Of The American Society For Microbiology |
|
| |
Genes Culled From Desert Soils Suggest Potential Medical Resource Despite their ecologic similarity, soils from three geographically distinct areas of the American southwest harbor vastly different collections of small, biosynthetic genes, a finding that suggests the existence of a far greater diversity of potentially useful products than was previously supposed... |
|
| |
|
|
| |
Reduced Glycerin Anti-HIV Product For Both Vagina And Rectum - Tenofovir Vaginal Gel |
|
| |
An anti-HIV gel developed for vaginal use has been reformulated to make it safer to use in the rectum. Researchers from the Microbicide Trials Network (MTN) found that tenofovir gel was less harmful to the lining of the rectum and just as effective in protecting cells against HIV. The study is published in the Journal of Antimicrobial Chemotherapy. Charlene Dezzutti, Ph.D... |
|
| |
|
|
| |
Anti-HIV Product For Both Vagina And Rectum Using Reduced Glycerin Formulation Of Tenofovir Vaginal Gel |
|
| |
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy... |
|
| |
|
|
